Stock WDH1 DEMANT A/S
Add to a list
To use this feature you must be a member
Log inSign up

Financials Demant A/S Berne S.E.

Equities

WDH1

DK0060738599

Medical Equipment, Supplies & Distribution

Delayed Berne S.E.
Other stock markets
 12:00:03 2023-11-15 pm EST 		5-day change 1st Jan Change
34.92 CHF -.--% Intraday chart for Demant A/S -19.92% -6.81%
Jun. 26 Demant Flags Delay in Completion of Communications Business' Strategic Review MT
May. 29 UK’s Competition Regulator Closes Cochlear-Demant Deal MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 51,461 57,664 80,200 42,434 64,150 65,006 - -
Enterprise Value (EV) 1 57,682 64,799 89,350 55,145 76,430 78,338 78,116 77,691
P/E ratio 35 x 51.4 x 31.3 x 20.9 x 36.8 x 21.6 x 18 x 15.5 x
Yield - - - - - - - -
Capitalization / Revenue 3.44 x 3.99 x 4.36 x 2.15 x 2.86 x 2.8 x 2.61 x 2.42 x
EV / Revenue 3.86 x 4.48 x 4.86 x 2.8 x 3.41 x 3.38 x 3.13 x 2.89 x
EV / EBITDA 18.5 x 25.1 x 19.7 x 12.6 x 13.9 x 12.8 x 11.7 x 10.7 x
EV / FCF 43.1 x 32 x 35.4 x 34.1 x 21.9 x 25.5 x 22.9 x 20 x
FCF Yield 2.32% 3.12% 2.83% 2.93% 4.56% 3.91% 4.36% 4.99%
Price to Book 6.68 x 6.99 x 9.67 x 5.02 x 7.07 x 6.4 x 5.32 x 4.34 x
Nbr of stocks (in thousands) 245,287 239,666 239,330 220,381 216,722 217,703 - -
Reference price 2 209.8 240.6 335.1 192.6 296.0 298.6 298.6 298.6
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/5/24 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,946 14,469 18,388 19,705 22,443 23,196 24,936 26,883
EBITDA 1 3,110 2,578 4,536 4,383 5,482 6,116 6,697 7,283
EBIT 1 2,151 1,313 3,386 3,207 4,148 4,746 5,223 5,715
Operating Margin 14.39% 9.07% 18.41% 16.28% 18.48% 20.46% 20.95% 21.26%
Earnings before Tax (EBT) 1 1,911 1,336 3,243 2,927 3,394 4,001 4,579 5,138
Net income 1 1,462 1,121 2,513 2,082 1,795 3,002 3,502 3,946
Net margin 9.78% 7.75% 13.67% 10.57% 8% 12.94% 14.04% 14.68%
EPS 2 6.000 4.680 10.70 9.210 8.040 13.85 16.55 19.25
Free Cash Flow 1 1,338 2,023 2,525 1,617 3,483 3,067 3,405 3,876
FCF margin 8.95% 13.98% 13.73% 8.21% 15.52% 13.22% 13.66% 14.42%
FCF Conversion (EBITDA) 43.02% 78.47% 55.67% 36.89% 63.54% 50.14% 50.85% 53.23%
FCF Conversion (Net income) 91.52% 180.46% 100.48% 77.67% 194.04% 102.16% 97.25% 98.23%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/5/24 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q2 2022 S1 2022 Q4 2022 S2 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales 1 7,596 6,078 8,391 9,012 9,376 4,894 9,497 5,345 10,208 5,647 11,155 5,403 5,885 11,288 5,575 5,851 11,347 5,687 6,192 11,959
EBITDA 1,528 629 1,949 2,162 2,374 893 2,128 - 2,255 - 2,662 - - 2,820 - - - - - -
EBIT 1,038 -193 1,506 1,638 1,748 - 1,588 - 1,619 - 2,014 - - 2,134 - - 2,196 - - 2,572
Operating Margin 13.67% -3.18% 17.95% 18.18% 18.64% - 16.72% - 15.86% - 18.05% - - 18.91% - - 19.35% - - 21.51%
Earnings before Tax (EBT) 917 26 1,310 1,536 1,707 - 1,493 - 1,434 - 1,655 - - 1,739 - - 1,900 - - 2,161
Net income 699 119 1,013 1,174 1,339 - 1,049 - 1,033 - 581 - - 1,214 - - - - - -
Net margin 9.2% 1.96% 12.07% 13.03% 14.28% - 11.05% - 10.12% - 5.21% - - 10.75% - - - - - -
EPS 2.880 0.5000 4.180 4.940 5.760 - 4.600 - 4.610 - - - - 5.440 - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/4/20 8/17/20 2/9/21 8/12/21 2/8/22 8/16/22 8/16/22 2/7/23 2/7/23 8/15/23 8/15/23 11/7/23 2/5/24 2/5/24 - - - - - -
1DKK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 6,221 7,135 9,150 12,711 12,280 13,332 13,110 12,684
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2 x 2.768 x 2.017 x 2.9 x 2.24 x 2.18 x 1.957 x 1.742 x
Free Cash Flow 1 1,338 2,023 2,525 1,617 3,483 3,067 3,405 3,877
ROE (net income / shareholders' equity) 19.5% 14.3% 30.7% 25.2% 28.5% 30.9% 31% 29.4%
ROA (Net income/ Total Assets) 7.36% 5.13% 10.7% 7.61% 8.45% 9.6% 10.7% 11.5%
Assets 1 19,867 21,852 23,394 27,359 21,243 31,276 32,661 34,404
Book Value Per Share 2 31.40 34.40 34.70 38.40 41.90 46.70 56.20 68.80
Cash Flow per Share 2 8.820 10.90 13.90 11.60 19.40 18.50 21.20 23.40
Capex 1 571 507 558 630 633 908 1,009 1,153
Capex / Sales 3.82% 3.5% 3.03% 3.2% 2.82% 3.91% 4.04% 4.29%
Announcement Date 2/4/20 2/9/21 2/8/22 2/7/23 2/5/24 - - -
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Demant A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
298.6 DKK
Average target price
331.2 DKK
Spread / Average Target
+10.91%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
STRAUMANN HOLDING AG Stock Straumann Holding AG
-15.19% 20.79B
SONOVA HOLDING AG Stock Sonova Holding AG
-1.17% 18.25B
COCHLEAR LIMITED Stock Cochlear Limited
+13.35% 14.9B
EMBLA MEDICAL HF. Stock Embla Medical hf.
+4.19% 1.79B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-31.27% 1.73B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
-0.53% 1.26B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
-4.88% 490M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 345M
DELCATH SYSTEMS, INC. Stock Delcath Systems, Inc.
+91.59% 221M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. DEMANT Stock
  4. WDH1 Stock
  5. Financials Demant A/S